Tuesday, 3 November 2026
M
Meridian Globe
Live briefing

Neoadjuvant apalutamide for high-risk prostate cancer

Source Nature 医学研究7d ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-120173df

Comments 0 comments

No comments yet. Be the first.

Neoadjuvant apalutamide for high-risk prostate cancer · Meridian Globe